Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DA-6034 vs Rebamipide in Acute or Chronic Gastritis
NCT01813812Phase 3Unknown
- Sponsor
- Dong-A Pharmaceutical
- Start
- Oct 2010
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of recoflavone in acute gastritis, chronic gastritis, sponsored by Dong-A Pharmaceutical. Status: unknown.
02
Drugs
recoflavone
03
Conditions
acute gastritischronic gastritis
Beyond the preview
Go deeper on NCT01813812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01813812.